Patent Assignment
Reel/Frame 017823/0219
2ND Amended and Restated U.S. Ip Security Agr. -June 30, 2005
Recorded: 2005-12-15
Received: 2006-04-20
Pages: 117
Assignors
INVERNESS MEDICAL SWITZERLAND GMBH
Executed: 2005-06-30
ISCHEMIA TECHNOLOGIES, INC.
Executed: 2005-06-30
Assignee
GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
2 BETHESDA METRO CENTER, SUITE 600, BETHESDA, MD, 20814, UNITED STATES
Covered Properties
(21)
Detection of impaired fertility
Application:
10/489,908 →
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
Application:
10/990,946 →
Particle agglutination detection method and device
Application:
10/885,688 →
Assessing Ovarian Reserve
Application:
10/469,666 →
System and Method for Flourescence Detection
Application:
10/500,186 →
Test methods and devices
Application:
10/780,904 →
Flow Sensing for Determination of Assay Results
Application:
10/742,459 →
Early Determination of Assay Results
Application:
10/741,416 →
Methods of using oxygen related protein 150 to diagnose and prognose heart disease
Application:
10/719,695 →
Assays and kits for detecting and monitoring heart disease
Application:
10/618,567 →
Apparatus and Method for Risk Stratification of Patients with Chest Pain of Suspected Cardiac Origin
Application:
10/441,155 →
Testing Device
Application:
29/176,573 →
Testing Device
Application:
29/176,574 →
Electrochemical assays
Application:
10/353,721 →
Assays
Application:
10/328,402 →
Assays
Application:
10/328,403 →
Assays
Application:
09/944,389 →
Peptides capable of functioning as mimotopes for hormonal analytes
Application:
09/920,306 →
Test Methods and Devices
Application:
09/824,587 →
Capillary Immunoassay and Device Therefor Comprising Mobilizable Particulate Labelled Reagents
Application:
09/794,061 →
Assays
Application:
09/780,351 →